MedKoo Cat#: 596754 | Name: Alaproclate hydrochloride, (S)-

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Alaproclate hydrochloride, (S)- is a selective serotonin reuptake inhibitor (SSRI), and along with zimelidine and indalpine, was one of the first of its kind.

Chemical Structure

Alaproclate hydrochloride, (S)-
CAS#57469-92-8 ( S isomer HCl)

Theoretical Analysis

MedKoo Cat#: 596754

Name: Alaproclate hydrochloride, (S)-

CAS#: 57469-92-8 ( S isomer HCl)

Chemical Formula: C13H19Cl2NO2

Exact Mass: 291.0793

Molecular Weight: 292.20

Elemental Analysis: C, 53.44; H, 6.55; Cl, 24.26; N, 4.79; O, 10.95

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Alaproclate hydrochloride, (S)-;
IUPAC/Chemical Name
1-(4-chlorophenyl)-2-methylpropan-2-yl L-alaninate hydrochloride
InChi Key
OPAKSOWFKIUFNP-FVGYRXGTSA-N
InChi Code
InChI=1S/C13H18ClNO2.ClH/c1-9(15)12(16)17-13(2,3)8-10-4-6-11(14)7-5-10;/h4-7,9H,8,15H2,1-3H3;1H/t9-;/m0./s1
SMILES Code
N[C@@H](C)C(OC(C)(C)CC1=CC=C(Cl)C=C1)=O.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 292.20 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Vilahur G, Casani L, Mendieta G, Lamuela-Raventos RM, Estruch R, Badimon L. Beer elicits vasculoprotective effects through Akt/eNOS activation. Eur J Clin Invest. 2014 Dec;44(12):1177-88. doi: 10.1111/eci.12352. PubMed PMID: 25323945. 2: Sun MK, Alkon DL. Cerebral ischemia-induced difference in sensitivity to depression and potential therapeutics in rats. Behav Pharmacol. 2013 Jun;24(3):222-8. doi: 10.1097/FBP.0b013e3283618afe. PubMed PMID: 23591125. 3: Clark TM, Lawecki JL, Shepherd JJ, Hirschler AN, Samandu TR. Effects of serotonergic agents on survival and hemolymph composition of the larval mosquito Aedes aegypti (Diptera: Culicidae, L.) in vivo: does serotonin regulate hemolymph acid-base homeostasis? J Exp Biol. 2009 Nov;212(Pt 22):3728-36. doi: 10.1242/jeb.032086. PubMed PMID: 19880735. 4: Cedeño N, Urbina M, Obregón F, Lima L. Characterization of serotonin transporter in blood lymphocytes of rats. Modulation by in vivo administration of mitogens. J Neuroimmunol. 2005 Feb;159(1-2):31-40. Epub 2004 Nov 4. PubMed PMID: 15652400. 5: Choi S, Jonak E, Fernstrom JD. Serotonin reuptake inhibitors do not prevent 5,7-dihydroxytryptamine-induced depletion of serotonin in rat brain. Brain Res. 2004 May 8;1007(1-2):19-28. PubMed PMID: 15064132. 6: Gong CL, Chiu YT, Lin NN, Lin SZ, Cheng FC, Kuo JS. Inhibitory actions of serotonin on glutamate release in dorsal medulla suppress systemic arterial pressure of cats. Neurosci Lett. 2004 Jan 23;355(1-2):73-6. PubMed PMID: 14729238. 7: Nicholson KL, Balster RL. Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats. Psychopharmacology (Berl). 2003 Nov;170(2):215-24. Epub 2003 Jul 8. PubMed PMID: 12851738. 8: Sun MK, Alkon DL. Open space swimming test to index antidepressant activity. J Neurosci Methods. 2003 Jun 15;126(1):35-40. PubMed PMID: 12788500. 9: Peña F, Ramirez JM. Endogenous activation of serotonin-2A receptors is required for respiratory rhythm generation in vitro. J Neurosci. 2002 Dec 15;22(24):11055-64. PubMed PMID: 12486201. 10: Wiley JL, Harvey SA, Balster RL, Nicholson KL. Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats. Psychopharmacology (Berl). 2003 Feb;165(4):378-85. Epub 2002 Nov 30. PubMed PMID: 12459931. 11: Howell LL, Hoffman JM, Votaw JR, Landrum AM, Wilcox KM, Lindsey KP. Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys. Psychopharmacology (Berl). 2002 Jan;159(2):154-60. Epub 2001 Oct 3. PubMed PMID: 11862343. 12: Czoty PW, Ginsburg BC, Howell LL. Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther. 2002 Mar;300(3):831-7. PubMed PMID: 11861788. 13: Lorrain DS, Matuszewich L, Friedman RD, Hull EM. Extracellular serotonin in the lateral hypothalamic area is increased during the postejaculatory interval and impairs copulation in male rats. J Neurosci. 1997 Dec 1;17(23):9361-6. PubMed PMID: 9364081. 14: Howell LL, Czoty PW, Byrd LD. Pharmacological interactions between serotonin and dopamine on behavior in the squirrel monkey. Psychopharmacology (Berl). 1997 May;131(1):40-8. PubMed PMID: 9181634. 15: Hu PS, Ross SB. NMDA receptor-mediated increase in cyclic GMP in the rat cerebellum in vivo is blocked by alaproclate and GEA-857. Pharmacol Toxicol. 1997 Feb;80(2):97-102. PubMed PMID: 9060041. 16: Li HT, Chen WY, Liu L, Yang CS, Cheng FC, Chai CY, Kuo JS. The dorsal facial area of the medulla in cats: inhibitory action of serotonin on glutamate release in regulating common carotid blood flow. Neurosci Lett. 1996 Jun 7;210(3):193-6. PubMed PMID: 8805128. 17: Allard P, Marcusson JO, Ross SB. [3H]WIN 35,428 binding in the human brain. Brain Res. 1996 Jan 15;706(2):347-50. PubMed PMID: 8822381. 18: Howell LL, Byrd LD. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther. 1995 Dec;275(3):1551-9. PubMed PMID: 8531128. 19: Rosén A, Franck J, Brodin E. Effects of acute systemic treatment with the 5 HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal grey. Neuropeptides. 1995 Jun;28(6):317-24. PubMed PMID: 7545268. 20: Ross SB. Comparison of high affinity binding of 3H-proadifen and 3H-(-)-cocaine to rat liver membranes. Pharmacol Toxicol. 1995 Feb;76(2):141-5. PubMed PMID: 7746799.